Derek J Theisen

6PUBLICATIONS
53CO-AUTHORS
Tumour immunologyCellular immunologyInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 16, 2026
CD4+ T cells play distinct roles during the priming versus effector phases of immune checkpoint therapy-dependent tumor elimination by CD8+ T cells.

|Apr 17, 2026
Immune Checkpoint Therapy Drives Maturation of a Cellular Neighborhood Nucleated by T Cell-APC Triads Enabling Spatially Compartmentalized Tumor Immunity.

|Feb 07, 2025
Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2.

Suin Jo, Ray A Ohara, Derek J Theisen

|Nov 29, 2018
Batf3-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation.

Derek J Theisen, Stephen T Ferris, Carlos G Briseño

|Nov 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Derek J Theisen, Jesse T Davidson, Carlos G Briseño

|May 10, 2018
NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells.

Gene I Uenishi, Ho Sun Jung, Akhilesh Kumar

Pageof 1

Frequent Collaborators

4 joint publications

Theresa L Murphy

2 joint publications

Samuel Ameh

2 joint publications

Ruan F Vieira Medrano

2 joint publications

Robert D Schreiber